Neumora Therapeutics, Inc.
NMRA
←Back to Recent Filings
| Filing |
DATE |
FP |
FY |
End Date |
URL |
VIEW |
|
| 8-K |
11/6/2025 |
Q3 |
2025 |
9/30/2025 |
SEC |
view |
data |
| 10-Q |
11/6/2025 |
Q3 |
2025 |
9/30/2025 |
SEC |
view |
|
| 8-K |
8/6/2025 |
Q2 |
2025 |
6/30/2025 |
SEC |
view |
data |
| 10-Q |
8/6/2025 |
Q2 |
2025 |
6/30/2025 |
SEC |
view |
|
| 8-K |
5/12/2025 |
Q1 |
2025 |
3/31/2025 |
SEC |
view |
data |
| 10-Q |
5/12/2025 |
Q1 |
2025 |
3/31/2025 |
SEC |
view |
|
| 8-K |
3/3/2025 |
Q4 |
2024 |
12/31/2024 |
SEC |
view |
data |
| 10-K |
3/3/2025 |
Q4 |
2024 |
12/31/2024 |
SEC |
view |
|
| 8-K |
11/12/2024 |
Q3 |
2024 |
9/30/2024 |
SEC |
view |
data |
| 10-Q |
11/12/2024 |
Q3 |
2024 |
9/30/2024 |
SEC |
view |
|
| 8-K |
8/6/2024 |
Q2 |
2024 |
6/30/2024 |
SEC |
view |
data |
| 10-Q |
8/6/2024 |
Q2 |
2024 |
6/30/2024 |
SEC |
view |
|
| 8-K |
5/7/2024 |
Q1 |
2024 |
3/31/2024 |
SEC |
view |
data |
| 10-Q |
5/7/2024 |
Q1 |
2024 |
3/31/2024 |
SEC |
view |
|
| 8-K |
3/7/2024 |
Q4 |
2023 |
12/31/2023 |
SEC |
view |
data |
| 10-K |
3/7/2024 |
Q4 |
2023 |
12/31/2023 |
SEC |
view |
|
| 8-K |
11/1/2023 |
Q3 |
2023 |
9/30/2023 |
SEC |
view |
data |
| 10-Q |
11/1/2023 |
Q3 |
2023 |
9/30/2023 |
SEC |
view |
|